Welcome to LookChem.com Sign In|Join Free
  • or
1,4-dibenzyl-4H-1,2,4-triazol-1-ium bromide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

128136-96-9

Post Buying Request

128136-96-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128136-96-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 128136-96-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,1,3 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 128136-96:
(8*1)+(7*2)+(6*8)+(5*1)+(4*3)+(3*6)+(2*9)+(1*6)=129
129 % 10 = 9
So 128136-96-9 is a valid CAS Registry Number.

128136-96-9Downstream Products

128136-96-9Relevant academic research and scientific papers

A New Mode of Operation of Pd-NHC Systems Studied in a Catalytic Mizoroki-Heck Reaction

Astakhov, Alexander V.,Khazipov, Oleg V.,Chernenko, Andrey Yu.,Pasyukov, Dmitry V.,Kashin, Alexey S.,Gordeev, Evgeniy G.,Khrustalev, Victor N.,Chernyshev, Victor M.,Ananikov, Valentine P.

, p. 1981 - 1992 (2017)

Metal complexes bearing N-heterocyclic carbene (NHC) ligands are typically considered the system of choice for homogeneous catalysis with well-defined molecular active species due to their stable metal-ligand framework. A detailed study involving 19 different Pd-NHC complexes with imidazolium, benzimidazolium, and triazolium ligands has been carried out in the present work and revealed a new mode of operation of metal-NHC systems. The catalytic activity of the studied Pd-NHC systems is predominantly determined by the cleavage of the metal-NHC bond, while the catalyst performance is strongly affected by the stabilization of in situ formed metal clusters. In the present study, the formation of Pd nanoparticles was observed from a broad range of metal complexes with NHC ligands under standard Mizoroki-Heck reaction conditions. A mechanistic analysis revealed two different pathways to connect Pd-NHC complexes to "cocktail"-type catalysis: (i) reductive elimination from a Pd(II) intermediate and the release of NHC-containing byproducts and (ii) dissociation of NHC ligands from Pd intermediates. Metal-NHC systems are ubiquitously applied in modern organic synthesis and catalysis, while the new mode of operation revealed in the present study guides catalyst design and opens a variety of novel opportunities. As shown by experimental studies and theoretical calculations, metal clusters and nanoparticles can be readily formed from M-NHC complexes after formation of new M-C or M-H bonds followed by C-NHC or H-NHC coupling. Thus, a combination of a classical molecular mode of operation and a novel cocktail-type mode of operation, described in the present study, may be anticipated as an intrinsic feature of M-NHC catalytic systems.

Synthesis and Anti-proliferative Activity of N,N′-bis-substituted 1,2,4-Triazolium Salts against Breast Cancer and Prostate Cancer Cell Lines

Lin, Zi Jie,Bies, Jared,Johnson, Shanina S.,Gorden, John D.,Strickland, Jacqueline F.,Frazier, Monica,Meyers, Jonathan M.,Shelton, Kerri L.

, p. 533 - 538 (2019)

A series of 1,4-N,N′-bis-substituted 1,2,4-triazolium bromide salts were synthesized and tested for anti-proliferative activity. 1,4-Bis(naphthalen-2-ylmethyl)-1,2,4-triazolium bromide (2) showed activity against MDA-MB-468 breast cancer and PC-3 prostate

Platinum(II) 1,2,4-Triazolin-5-ylidene Complexes: Stereoelectronic Influences on Their Catalytic Activity in Hydroelementation Reactions

Dang, Thanh Tuan,Huynh, Han Vinh,Nguyen, Hung Huy,Nguyen, Van Ha

, (2020)

Five platinum(II) 1,2,4-triazolin-5-ylidene (tazy) complexes of the general formula [PtCl2(DMSO)(R-tazy)] (1-5), bearing different N4 substituents (R = Dipp (1), Mes (2), Ph (3), Nap (4), and Bn (5)), have been successfully synthesized. The compounds have

TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF

-

Page/Page column 26, (2011/10/31)

The present disclosure relates to certain new and known triazolium and/or imidazolium salts and to their therapeutic use, for example in methods of treating or preventing an infection by a Plasmodium or Babesia parasite in a subject in need thereof. The triazolium and imidazolium salts are compounds of the Formula (I) or (II): wherein R1-R4, R1′-R3′, R8-R11, X, X′, X″, Y, Y′ and Y″ are as defined in the disclosure.

Anti-Plasmodium activity of imidazolium and triazolium salts

Vlahakis, Jason Z.,Lazar, Carmen,Crandall, Ian E.,Szarek, Walter A.

experimental part, p. 6184 - 6196 (2010/09/14)

We have previously reported that tetrazolium salts were both potent and specific inhibitors of Plasmodium replication, and that they appear to interact with a parasite component that is both essential and conserved. The use of tetrazolium salts in vivo is limited by the potential reduction of the tetrazolium ring to form an inactive, neutral acyclic formazan. To address this issue imidazolium and triazolium salts were synthesized and evaluated as Plasmodium inhibitors. Many of the imidazolium and triazolium salts were highly potent with active concentrations in the nanomolar range in Plasmodium falciparum cultures, and specific to Plasmodium with highly favorable therapeutic ratios. The results corroborate our hypothesis that an electron-deficient core is required so that the compound may thereby interact with a negatively charged moiety on the parasite merozoite; the side groups in the compound then form favorable interactions with adjacent parasite components and thereby determine both the potency and selectivity of the compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 128136-96-9